{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:25:27Z","timestamp":1791595527705,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T00:00:00Z","timestamp":1306800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/bjc.2011.185","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T19:55:23Z","timestamp":1306871723000},"page":"28-37","source":"Crossref","is-referenced-by-count":299,"title":["End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24\u201345 years of age"],"prefix":"10.1038","volume":"105","author":[{"given":"X","family":"Castellsagu\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Pitisuttithum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Monsonego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mallary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O M","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Vuocolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Saah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"issue":"Suppl 3","key":"BFbjc2011185_CR1","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.ygyno.2009.09.021","volume":"115","author":"X Castellsague","year":"2009","unstructured":"Castellsague X, Schneider A, Kaufmann AM, Bosch FX (2009) HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 115 (Suppl 3): S15\u2013S23","journal-title":"Gynecol Oncol"},{"issue":"9490","key":"BFbjc2011185_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (9490): 991\u2013998","journal-title":"Lancet"},{"issue":"7","key":"BFbjc2011185_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjose","year":"2007","unstructured":"de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 (7): 453\u2013459","journal-title":"Lancet Infect Dis"},{"key":"BFbjc2011185_CR4","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.297.8.813","volume":"297","author":"EF Dunne","year":"2007","unstructured":"Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE (2007) Prevalence of HPV infection among females in the United States. JAMA 297: 813\u2013819","journal-title":"JAMA"},{"issue":"19","key":"BFbjc2011185_CR5","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GWK, Ferris DG, Steben M, Bryan JT, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA (2007) Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356 (19): 1928\u20131943","journal-title":"N Engl J Med"},{"key":"BFbjc2011185_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-9378-2-15","volume":"2","author":"RP Insinga","year":"2007","unstructured":"Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E (2007) Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infect Agent Cancer 2: 15","journal-title":"Infect Agent Cancer"},{"key":"BFbjc2011185_CR7","unstructured":"International Agency for Research on Cancer Working Group. Human Papillomaviruses. [90]. (2007). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC: Lyon, France, IARC."},{"key":"BFbjc2011185_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2","volume":"87","author":"MV Jacobs","year":"2000","unstructured":"Jacobs MV, Walboomers JMM, Snijders PJF, Voorhorst FJ, Verheijen RHM, Fransen-Daalmeijer N, Meijer CJLM (2000) Distribution of 37 mucosotropic HPV types in women with cytologically normal cervial smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87: 221\u2013227","journal-title":"Int J Cancer"},{"issue":"52","key":"BFbjc2011185_CR9","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1016\/j.vaccine.2008.09.073","volume":"26","author":"EA Joura","year":"2008","unstructured":"Joura EA, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch X, Dillner J, Kurman RJ, Majewski S, Munoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Lu S, Vuocolo S, Hesley TM, Haupt RM, Barr E (2008) HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine 26 (52): 6844\u20136851","journal-title":"Vaccine"},{"issue":"6","key":"BFbjc2011185_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00eb X, Shah KV, Snijders PJF, Meijer CJLM, for the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (6): 518\u2013527","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"BFbjc2011185_CR11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","volume":"24","author":"N Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz N, Castellsague X, de Gonzalez AB, Gissmann L (2006) HPV in the etiology of human cancer. Vaccine 24 (Suppl 3): S1\u2013S10","journal-title":"Vaccine"},{"key":"BFbjc2011185_CR12","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(09)60691-7","volume":"373","author":"N Munoz","year":"2009","unstructured":"Munoz N, Manalastas R, Pitisuttihum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo F, Esser M, Vuocolo S, Haupt R, Barr E, Saah A (2009) Safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women between 24 and 45 years of age: a randomized, double-blind trial. Lancet 373: 1921\u20131922","journal-title":"Lancet"},{"issue":"190","key":"BFbjc2011185_CR13","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1086\/425907","volume":"15","author":"N Munoz","year":"2004","unstructured":"Munoz N, Mendez F, Posso H, Molano M, van den Brule AJ, Ronderos M, Meijer C, Munoz A, Instituto Nacional de Cancerologia HPV study group (2004) Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 15 (190): 2077\u20132087","journal-title":"J Infect Dis"},{"key":"BFbjc2011185_CR14","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","volume":"25","author":"S-E Olsson","year":"2007","unstructured":"Olsson S-E, Villa LL, Costa R, Petta C, Andrade R, Malm C, Iversen O-E, Hoye J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom A, Elfgren K, von Krogh G, Lehtinen M, Paavonen J, Tamms G, Giacoletti K, Lupinacci L, Esser M, Vuocolo S, Saah AJ, Barr E (2007) Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like-particle vaccine. Vaccine 25: 4931\u20134939","journal-title":"Vaccine"},{"issue":"1","key":"BFbjc2011185_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/CDLI.10.1.108-115.2003","volume":"10","author":"D Opalka","year":"2003","unstructured":"Opalka D, Lachman CE, MacMullen SA, Jansen KU, Smith JF, Chirmule N, Esser MT (2003) Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16 and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol 10 (1): 108\u2013115","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"BFbjc2011185_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jnci\/djq001","volume":"102","author":"AC Rodriguez","year":"2010","unstructured":"Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD (2010) Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection. J Natl Cancer Inst 102 (5): 315\u2013324","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2011185_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","volume":"31","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Kjaer SK (2003) Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31: 14\u201319","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"16","key":"BFbjc2011185_CR18","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R, Moriarty A, O\u2019Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright Jr T, Young N (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287 (16): 2114\u20132119","journal-title":"JAMA"},{"issue":"10","key":"BFbjc2011185_CR19","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1086\/522864","volume":"196","author":"The FUTURE II Study Group","year":"2007","unstructured":"The FUTURE II Study Group (2007a) Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virologic evidence of HPV infection. J Infect Dis 196 (10): 1438\u20131446","journal-title":"J Infect Dis"},{"issue":"19","key":"BFbjc2011185_CR20","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"The FUTURE II Study Group","year":"2007","unstructured":"The FUTURE II Study Group (2007b) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356 (19): 1915\u20131927","journal-title":"N Engl J Med"},{"issue":"1","key":"BFbjc2011185_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JMM Walboomers","year":"1999","unstructured":"Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer A, Shah KV, Snijders PJF (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1): 12\u201319","journal-title":"J Pathol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2011185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011185","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:01:25Z","timestamp":1684414885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2011185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["BFbjc2011185"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2011.185","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}